Differential response of estrogen receptor subtypes to 1,3-diarylindene and 2,3-diarylindene ligands

被引:116
作者
Clegg, NJ
Paruthiyil, S
Leitman, DC
Scanlan, TS
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA
关键词
D O I
10.1021/jm050226i
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Estrogen receptors (ERs) control transcription of genes important for normal human development and reproduction. The signaling networks are complex, and there is a need for a molecular level understanding of the roles of receptor subtypes ER alpha and ER beta in normal physiology and as therapeutic targets. We synthesized two series of ER ligands, based on a common indene scaffold, in an attempt to develop compounds that can selectively modulate ER-mediated transcription. The 3-ethyl-1,2-diarylindenes, utilizing an amide linker for the 1-aryl extension, bind weakly to the ERs. The 2,3-diarylindenes bind with high affinity to the ER subtypes and demonstrate a range of different biological activities, both in transcriptional reporter gene assays and inhibition of estradiol-stimulated proliferation of MCF-7 cells. Several ligands differentiate between ER alpha and ER beta subtypes at an estrogen response element (ERE), displaying various levels of partial to full agonist activity at ER alpha, while antagonizing estradiol action at ER beta.
引用
收藏
页码:5989 / 6003
页数:15
相关论文
共 65 条
[21]   ALKYLATIONS AT THE ALPHA-CARBON OF PHENYLACETIC AND DIPHENYLACETIC ACIDS WITH BENZYL CHLORIDE AND RELATED HALIDES BY ALKALI AMIDES [J].
HAUSER, CR ;
CHAMBERS, WJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1956, 78 (19) :4942-4944
[22]  
HONE BD, 1998, ORGANOSILICON COMPOU
[23]   5,6,11,12-TETRAHYDROCHRYSENES - SYNTHESIS OF RIGID STILBENE SYSTEMS DESIGNED TO BE FLUORESCENT LIGANDS FOR THE ESTROGEN-RECEPTOR [J].
HWANG, KJ ;
ONEIL, JP ;
KATZENELLENBOGEN, JA .
JOURNAL OF ORGANIC CHEMISTRY, 1992, 57 (04) :1262-1271
[24]   Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions [J].
Jordan, VC .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (06) :883-908
[25]  
KATZENELLENBOGEN BS, 1984, CANCER RES, V44, P112
[26]   FACILE GEOMETRIC ISOMERIZATION OF PHENOLIC NON-STEROIDAL ESTROGENS AND ANTIESTROGENS - LIMITATIONS TO THE INTERPRETATION OF EXPERIMENTS CHARACTERIZING THE ACTIVITY OF INDIVIDUAL ISOMERS [J].
KATZENELLENBOGEN, JA ;
CARLSON, KE ;
KATZENELLENBOGEN, BS .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1985, 22 (05) :589-596
[27]   Synthesis and relative binding affinity to steroid receptors and antiproliferative activity on MCF-7 cells of 2,3-disubstituted indenes [J].
Kirkiacharian, S ;
Koutsourakis, PG ;
Philibert, D ;
Bouchoux, F ;
Van de Velde, P .
FARMACO, 1999, 54 (10) :678-683
[28]   Mutational analysis of the estrogen receptor ligand-binding domain: Influence of ligand structure and stereochemistry on transactivation [J].
Kohno, H ;
Bocchinfuso, WP ;
Gandini, O ;
Curtis, SW ;
Korach, KS .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1996, 16 (03) :277-285
[29]   ESTROGENIC ACTIVITY INVIVO AND INVITRO OF SOME DIETHYLSTILBESTROL METABOLITES AND ANALOGS [J].
KORACH, KS ;
METZLER, M ;
MCLACHLAN, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (01) :468-471
[30]  
KORACH KS, 1985, J BIOL CHEM, V260, P5420